CTLA4 and neoplasm: Hence, given the imbalance between CD4+ T‐cell subsets, we propose adoptive T‐cell therapy (tumour reactive CD4+ Th‐cell reinfusion), CAR T‐cell therapy and immune checkpoint blockade, such as anti‐CTLA4, to reactivate Th cells and inhibit Treg cells.